BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19424020)

  • 1. Using biomarkers of tolerance and rejection to identify high- and low-risk patients following kidney transplantation.
    Ashton-Chess J; Giral M; Soulillou JP; Brouard S
    Transplantation; 2009 May; 87(9 Suppl):S95-9. PubMed ID: 19424020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can we use biomarkers and functional assays to implement personalized therapies in transplantation?
    Sawitzki B; Pascher A; Babel N; Reinke P; Volk HD
    Transplantation; 2009 Jun; 87(11):1595-601. PubMed ID: 19502949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in renal transplantation.
    Bestard O; Cruzado JM; la Franquesa M; Grinyó JM
    Curr Opin Organ Transplant; 2010 Aug; 15(4):467-73. PubMed ID: 20613522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring tolerance and rejection in organ transplant recipients.
    Sawitzki B; Schlickeiser S; Reinke P; Volk HD
    Biomarkers; 2011 Jul; 16 Suppl 1():S42-50. PubMed ID: 21707443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
    Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant anti-HLA antibodies: risk factor for chronic rejection?
    Buchler M; al Najjar A; Guerraoui A; Valentin JF; Boulanger MD; Sherobeen R; Lataste A; Nivet H; Lebranchu Y
    Transplant Proc; 1995 Aug; 27(4):2478-9. PubMed ID: 7652894
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-transplant monitoring of renal allografts: are we there yet?
    Nickerson P
    Curr Opin Immunol; 2009 Oct; 21(5):563-8. PubMed ID: 19713093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.
    Ismail AM; Badawi RM; El-Agroudy AE; Mansour MA
    Exp Clin Transplant; 2009 Jun; 7(2):104-9. PubMed ID: 19715514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic allograft nephropathy.
    Najafian B; Kasiske BL
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients.
    Ibis A; Akgül A; Ozdemir N; Colak T; Sezer S; Arat Z; Haberal M
    Transplant Proc; 2009 Jun; 41(5):1604-8. PubMed ID: 19545689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney transplantation: graft monitoring and immunosuppression.
    Fisher JS; Woodle ES; Thistlethwaite JR
    World J Surg; 2002 Feb; 26(2):185-93. PubMed ID: 11865349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression of the elderly kidney transplant recipient.
    Danovitch GM; Gill J; Bunnapradist S
    Transplantation; 2007 Aug; 84(3):285-91. PubMed ID: 17700150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune monitoring of kidney transplant recipients: can markers predictive of over-immunosuppression be identified?].
    Saas P; Courivaud C; Bamoulid J; Garnache-Ottou F; Seilles E; Ducloux D
    Ann Pharm Fr; 2008 Mar; 66(2):115-21. PubMed ID: 18570910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients.
    Braudeau C; Ashton-Chess J; Giral M; Dugast E; Louis S; Pallier A; Braud C; Moreau A; Renaudin K; Soulillou JP; Brouard S
    Transplantation; 2008 Jul; 86(1):130-6. PubMed ID: 18622290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring and treatment strategy for chronic renal allograft rejection].
    Kyo M; Namba Y; Takahara S
    Nihon Jinzo Gakkai Shi; 2008; 50(7):894-8. PubMed ID: 19069146
    [No Abstract]   [Full Text] [Related]  

  • 17. Early diagnosis and successful treatment of acute antibody-mediated rejection of a renal transplant.
    Yang YW; Lin WC; Wu MS; Lee PH; Tsai MK
    Exp Clin Transplant; 2008 Sep; 6(3):211-4. PubMed ID: 18954299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperimmunized patients awaiting cadaveric kidney graft: is there a quick desensitization possible?
    Faenza A; Fuga G; Bertelli R; Scolari MP; Buscaroli A; Stefoni S
    Transplant Proc; 2008; 40(6):1833-8. PubMed ID: 18675064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor.
    Gupta A; Sinnott P
    Hum Immunol; 2009 Aug; 70(8):618-22. PubMed ID: 19374932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.